1. P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES. (23rd June 2022) Authors: Rai, S.; Hess, L.; Chen, Y.; Abada, P.; Konig, H.; Walgren, R.; Tanizawa, Y.; Cai, Z.; Tajimi, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1024 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗